San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. The company
At ADA 2026, Dexcom said it planned to offer select users the opportunity for early access to a reimagined app experience for its Stelo OTC continuous glucose monitor (CGM). The company said it received FDA clearance for the updated app last month. This launch also comes on the heels of FDA clearance for Stelo for children, announced by the FDA earlier this month.
Get the full story at our sister site, Drug Delivery Business News.
